Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Lyophilized Products : SOP for Reconstitution Testing of Lyophilized Products

Posted on By

SOP for Reconstitution Testing of Lyophilized Products

Standard Operating Procedure for Reconstitution Testing of Lyophilized Products

1) Purpose

This SOP outlines the procedure for testing the reconstitution of lyophilized products to ensure that the product dissolves fully and retains its intended potency and stability after reconstitution.

2) Scope

This SOP applies to laboratory personnel responsible for conducting reconstitution testing and verifying product quality after the lyophilization process.

3) Responsibilities

  • Laboratory Personnel: Responsible for performing reconstitution tests according to the Batch Manufacturing Record (BMR).
  • QA Personnel: Responsible for verifying that reconstitution tests meet product specifications and regulatory guidelines.
See also  SOP for Weighing and Dispensing of Raw Materials for Lyophilization

4) Procedure

4.1 Reconstitution Protocol

4.1.1 Preparation

  • 4.1.1.1 Ensure that the appropriate diluent (as specified in the BMR) is used for reconstituting the lyophilized product.
  • 4.1.1.2 Use the specified volume of diluent and dissolve the lyophilized product by gently swirling or inverting the vial, avoiding vigorous shaking.

4.2 Testing Parameters

4.2.1 Time to Dissolve

  • 4.2.1.1 Record the time it takes for the lyophilized product to completely dissolve in the diluent. The product should dissolve within the time limit specified in the BMR.

4.2.2 Visual Clarity

  • 4.2.2.1 Inspect the reconstituted solution for clarity. It should be free of particulates or turbidity unless otherwise specified in the product specifications.
See also  SOP for Monitoring pH in Lyophilized Formulations

4.2.3 Potency Testing

  • 4.2.3.1 Conduct potency assays to ensure the product retains its therapeutic efficacy after
reconstitution.

4.3 Documentation

Document all reconstitution testing results in the Reconstitution Testing Logbook. Ensure that all entries are verified by QA personnel before releasing the batch for further use.

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Reconstitution Testing Logbook

7) References

  • Pharmacopoeial guidelines for reconstitution testing of lyophilized products

8) SOP Version

Version 1.0

Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Safe Handling of Nanoparticles and Nanomaterials
Next Post: Lyophilized Products : SOP for Storage and Handling of Lyophilized Products

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version